Sensus Healthcare Inc (SRTS): Market Cap to Revenue

Symbol and logo of brand Sensus Healthcare Inc (SRTS)

Sensus Healthcare, Inc. (SRTS) develops high-cost skin cancer therapy systems, generating revenue through software sales and services. The P/S multiple helps evaluate the business value relative to revenue, while 3.00 indicates the level of this metric. A stable moat is provided by the uniqueness of non-invasive methodologies, and experienced management is systematically integrating the equipment into dermatological practice, expanding its market presence.

SRTS Sensus Healthcare Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Sensus Healthcare Corp (SRTS)

- share price and consensus valuation forecast:
General company analysis:SRTS sensushealthcare.com
Core merchandise of Sensus Healthcare, Inc.

The P/S ratio compares market capitalization to annual sales volume, determining the value of each dollar of revenue in the eyes of investors. For Sensus Healthcare, Inc. (SRTS), this metric reflects the market premium on B2B radiation therapy equipment sales. By analyzing the business valuation via P/S, one can identify if the asset is overbought relative to the pace of expansion across oncology centers. A stable trend in this indicator confirms the investment resilience of a model characterized by rapid equipment payback.

Competitors of Sensus Healthcare, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|GCTK (GlucoTrack, Inc.) - P/S Multiple|Price to Sales nanovibronix.com NAOV|Price-to-Revenue Ratio Venus Concept Corp (VERO)|Nuwellis Corp - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Aethlon Medical AEMD|Price-to-Revenue Coefficient Asensus Surgical Inc (ASXC)|AVGR: Market Cap to Revenue|BSGM - P/S Multiple|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|KNW - Price-to-Revenue Coefficient|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio